ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Design, synthesis and pharmacological evaluation of 2-arylurea-1,3,5-tria-zine derivative (XIN-9): A novel potent dual PI3K/mTOR inhibitor for cancer therapy

Sun, Xin; Zhang, Binliang; Luo, Leixuan; Yang, Yang; He, Bin; Zhang, Qian; Wang, Linxiao; Xu, Shan*; Zheng, Pengwu*; Zhu, Wufu*jiangxi sci & technol normal univ
Bioorganic Chemistry2022-12DOI: 10.1016/j.bioorg.2022.106157
10被引5阅读
引用收藏
分享

摘要

Blocking the PI3K/AKT/mTOR pathway has been widely recognized as an attractive cancer therapeutic strategy because of its crucial role in cell growth and survival. In this study, a novel series of 2-arylurea-1,3,5-triazine derivatives had been synthesized and evaluated as highly potent PI3K and mTOR inhibitors. The new com-pounds exhibited cytotoxic activities against MCF-7, Hela and A549 cancer cell lines (IC50 = 0.03-36.54 mu M). The most promising compound XIN-9 exhibited potent inhibition against PI3K and mTOR kinase (IC50 = 23.8 and 10.9 nM). Mechanistic study using real-time PCR revealed the ability of XIN-9 to inhibit PI3K and mTOR. In addition, compound XIN-9 arrested the cell cycle of MCF-7 cells at the G0/G1 phase. XIN-9 also caused a sig-nificant dose-dependent increase of early and late apoptotic events. Molecular docking analysis revealed a high binding affinity for XIN-9 toward PI3K and mTOR. Following in vitro studies, XIN-9 was further evaluated in MCF-7 xenograft models to show significant in vivo anticancer efficacies with tumor growth inhibitions of 41.67% (po, 75 mg/kg). Overall, this work indicated that compound XIN-9 represents a potential anticancer targeting PI3K/AKT/mTOR pathway.

学科与关键词

关键词
PI3KmTORInhibitor2-arylurea-135-triazineStructure-activity relationshipCytotoxicity
相关
加载中…
  • Design, synthesis and pharmacological evaluation of 2-arylurea-1,3,5-triazine derivative (XIN-9): A novel potent dual PI3K/mTOR inhibitor for cancer therapy (vol 129, 106157, 2022 )
    Sun, Xin; Zhang, Binliang; Luo, Leixuan; Yang, Yang; He, Bin; Zhang, Qian; Wang, Linxiao; Xu, Shan*; Zheng, Pengwu*; Zhu, Wufu*Bioorganic Chemistry, 2023, 131: 106336.
  • Design, synthesis and bioevaluation of novel substituted triazines as potential dual PI3K/mTOR inhibitors
    Wu, Ting-Ting; Guo, Qing-Qing; Chen, Zi-Li; Wang, Li-Li; Du, Yao; Chen, Rui; Mao, Yuan-Hu; Yang, Sheng-Gang; Huang, Jing; Wang, Jian-Ta; Wang, Ling; Tang, Lei*; Zhang, Ji-Quan*European Journal of Medicinal Chemistry, 2020, 204: 112637.被引 26
  • Function-oriented synthesis of Imidazo[1,2-a]pyrazine and Imidazo[1,2-b] pyridazine derivatives as potent PI3K/mTOR dual inhibitors
    Li, Chuchu; Han, Yuqiao; Wang, Zhengyang; Yu, Yanan; Wang, Chen; Ren, Ziwei; Guo, Yanzhi; Zhu, Tong; Li, XuWen*; Dong, Suzhen*; Ma, Mingliang*European Journal of Medicinal Chemistry, 2023, 247: 115030.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioorganic Chemistry
发表日期
2022-12
卷期
第 129 卷
页码
106157
DOI
10.1016/j.bioorg.2022.106157
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [21967009,82060629]; Natural Science Foundation of Jiangxi, China [20202BABL216076, 20192BAB215061]; Science and Technology Project Founded by the Education Department of Jiangxi Province, China [GJJ190583]; Youth Top Talent Support Program of Jiangxi Science & Technology Normal University [2019QNBJRC008]; Nanchang Key Laboratory of Molecular Targeted Anticancer Drug Design and Evaluation [2019-NCZDSY-007]

作者

  • S

    Sun, Xin (第一作者)

    jiangxi sci & technol normal univ

  • Z

    Zhang, Binliang

    jiangxi sci & technol normal univ

查看全部 10 位作者收起作者
  • L

    Luo, Leixuan

    jiangxi sci & technol normal univ

  • Y

    Yang, Yang

    jiangxi sci & technol normal univ

  • H

    He, Bin

    jiangxi sci & technol normal univ

  • Z

    Zhang, Qian

    jiangxi sci & technol normal univ

  • W

    Wang, Linxiao

    jiangxi sci & technol normal univ

  • X

    Xu, Shan (通讯)

    jiangxi sci & technol normal univ

  • Z

    Zheng, Pengwu (通讯)

    jiangxi sci & technol normal univ

  • Z

    Zhu, Wufu (通讯)

    jiangxi sci & technol normal univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417